Roles of systemic inflammatory and metabolic responses in the pathophysiology of acute-on-chronic liver failure

Gu, 2021, Trends and the course of liver cirrhosis and its complications in Germany: nationwide population-based study (2005 to 2018), Lancet Reg Health Eur, 12 Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042 Arroyo, 2020, Acute-on-Chronic liver failure, N Engl J Med, 382, 2137, 10.1056/NEJMra1914900 Arroyo, 2016, Acute-on-chronic liver failure in cirrhosis, Nat Rev Dis Primers, 2, 10.1038/nrdp.2016.41 Weiss, 2021, Characterization of blood immune cells in patients with decompensated cirrhosis including ACLF, Front Immunol, 11, 10.3389/fimmu.2020.619039 Clària, 2016, Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure, Hepatology, 64, 1249, 10.1002/hep.28740 Trebicka, 2019, Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis, Front Immunol, 10, 476, 10.3389/fimmu.2019.00476 Trebicka, 2020, The Predict study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology, J Hepatol, 73, 842, 10.1016/j.jhep.2020.06.013 Monteiro, 2021, Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation, Gut, 70, 379 Trebicka, 2021, PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis, J Hepatol, 74, 1097, 10.1016/j.jhep.2020.11.019 Fernández, 2018, Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis, Gut, 67, 1870, 10.1136/gutjnl-2017-314240 Medzhitov, 2008, Origin and physiological roles of inflammation, Nature, 454, 428, 10.1038/nature07201 Medzhitov, 2012, Disease tolerance as a defense strategy, Science, 335, 936, 10.1126/science.1214935 Iwasaki, 2015, Control of adaptive immunity by the innate immune system, Nat Immunol, 16, 343, 10.1038/ni.3123 Annunziato, 2015, The 3 major types of innate and adaptive cell-mediated effector immunity, J Allergy Clin Immunol, 135, 626, 10.1016/j.jaci.2014.11.001 Rankin, 2018, Beyond host defense: emerging functions of the immune system in regulating complex tissue physiology, Cell, 173, 554, 10.1016/j.cell.2018.03.013 Wang, 2019, An evolutionary perspective on immunometabolism, Science, 363, eaar3932, 10.1126/science.aar3932 Florsheim, 2021, Food allergy as a biological food quality control system, Cell, 184, 1440, 10.1016/j.cell.2020.12.007 Medzhitov, 2021, The spectrum of inflammatory responses, Science, 374, 1070, 10.1126/science.abi5200 Mayassi, 2021, A multilayered immune system through the lens of unconventional T cells, Nature, 595, 501, 10.1038/s41586-021-03578-0 Ganeshan, 2014, Metabolic regulation of immune responses, Annu Rev Immunol, 32, 609, 10.1146/annurev-immunol-032713-120236 Ganeshan, 2019, Energetic trade-offs and hypometabolic states promote disease tolerance, Cell, 177, 399, 10.1016/j.cell.2019.01.050 Sanderson, 2019, Methionine metabolism in health and cancer: a nexus of diet and precision medicine, Nat Rev Cancer, 19, 625, 10.1038/s41568-019-0187-8 Shi, 2015, Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults, Hepatology, 62, 232, 10.1002/hep.27795 Schütte, 2019, Influenza virus infection as precipitating event of acute-on-chronic liver failure, J Hepatol, 70, 797, 10.1016/j.jhep.2018.11.015 Fernández, 2021, Management of bacterial and fungal infections in cirrhosis: the MDRO challenge, J Hepatol, 75, 101, 10.1016/j.jhep.2020.11.010 Piano, 2019, Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide, Gastroenterology, 156, 1368, 10.1053/j.gastro.2018.12.005 Van der Merwe, 2021, The multifactorial mechanisms of bacterial infection in decompensated cirrhosis, J Hepatol, 75, S82, 10.1016/j.jhep.2020.11.029 Trebicka, 2021, Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure, Nat Rev Gastroenterol Hepatol, 18, 167, 10.1038/s41575-020-00376-3 Macdonald, 2018, Cell death markers in patients with cirrhosis and acute decompensation, Hepatology, 67, 989, 10.1002/hep.29581 Bataller, 2022, Alcohol-associated hepatitis, N Engl J Med, 387, 2436, 10.1056/NEJMra2207599 Sharma, 2017, Pre-therapy liver transcriptome landscape in Indian and French patients with severe alcoholic hepatitis and steroid responsiveness, Sci Rep, 7, 6816, 10.1038/s41598-017-07161-4 He, 2017, Senescence in health and disease, Cell, 169, 1000, 10.1016/j.cell.2017.05.015 Duan, 2019, Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease, Nature, 575, 505, 10.1038/s41586-019-1742-x Jiang, 2020, Intestinal virome in patients with alcoholic hepatitis, Hepatology, 72, 2182, 10.1002/hep.31459 Lang, 2020, Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis, Hepatology, 71, 522, 10.1002/hep.30832 Karakike, 2017, Infections in severe alcoholic hepatitis, Ann Gastroenterol, 30, 152 Chen, 2003, The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion, Nat Med, 9, 575, 10.1038/nm849 Fajgenbaum, 2020, Cytokine storm, N Engl J Med, 383, 2255, 10.1056/NEJMra2026131 Dennis, 2015, Eicosanoid storm in infection and inflammation, Nat Rev Immunol, 15, 511, 10.1038/nri3859 Funk, 2001, Prostaglandins and leukotrienes: advances in eicosanoid biology, Science, 294, 1871, 10.1126/science.294.5548.1871 Samuelsson, 2012, Role of basic science in the development of new medicines: examples from the eicosanoid field, J Biol Chem, 287, 10070, 10.1074/jbc.X112.351437 Samuelsson, 1983, Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation, Science, 220, 568, 10.1126/science.6301011 Clària, 2003, Prostaglandins and other cyclooxygenase-dependent arachidonic acid metabolites and the kidney in liver disease, Prostaglandins Other Lipid Mediat, 72, 19, 10.1016/S1098-8823(03)00075-3 O'Brien, 2014, Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2, Nat Med, 20, 518, 10.1038/nm.3516 López-Vicario, 2020, Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis, J Hepatol, 73, 817, 10.1016/j.jhep.2020.03.046 Casulleras, 2022, Albumin lipidomics reveals meaningful compositional changes in advanced cirrhosis and its potential to promote inflammation resolution, Hepatol Commun, 6, 1443, 10.1002/hep4.1893 Clària, 1998, Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with liver cirrhosis, Gastroenterology, 115, 147, 10.1016/S0016-5085(98)70376-2 Simopoulos, 2008, The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases, Exp Biol Med, 233, 674, 10.3181/0711-MR-311 Sánchez-Rodríguez, 2022, Reduced plasma extracellular vesicle CD5L content in patients with acute-on-chronic liver failure: interplay with specialized pro-resolving lipid mediators, Front Immunol, 13, 10.3389/fimmu.2022.842996 Becares, 2020, Immune regulatory mediators in plasma from patients with acute decompensation are associated with 3-month mortality, Clin Gastroenterol Hepatol, 18, 1207, 10.1016/j.cgh.2019.08.036 Manz, 2014, Emergency granulopoiesis, Nat Rev Immunol, 14, 302, 10.1038/nri3660 Korf, 2019, Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity, Gut, 68, 1872, 10.1136/gutjnl-2018-316888 Bernsmeier, 2015, Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK, Gastroenterology, 148, 603, 10.1053/j.gastro.2014.11.045 Bernsmeier, 2018, CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure, Gut, 67, 1155, 10.1136/gutjnl-2017-314184 Zagórska, 2014, Diversification of TAM receptor tyrosine kinase function, Nat Immunol, 15, 920, 10.1038/ni.2986 Rothlin, 2007, TAM receptors are pleiotropic inhibitors of the innate immune response, Cell, 131, 1124, 10.1016/j.cell.2007.10.034 Weiss, 2017, Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome, J Hepatol, 66, 930, 10.1016/j.jhep.2016.12.008 Weichselbaum, 2020, Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis, J Hepatol, 73, 303, 10.1016/j.jhep.2020.02.017 Hotchkiss, 2020, Activating immunity to fight a foe - a new path, N Engl J Med, 382, 1270, 10.1056/NEJMcibr1917242 Clària, 2019, Orchestration of tryptophan-kynurenine pathway, acute decompensation, and acute-on-chronic liver failure in cirrhosis, Hepatology, 69, 1686, 10.1002/hep.30363 Belladonna, 2007, Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes, Transplantation, 84, S17, 10.1097/01.tp.0000269199.16209.22 Nakai, 2014, Control of lymphocyte egress from lymph nodes through β2-adrenergic receptors, J Exp Med, 211, 2583, 10.1084/jem.20141132 Moreau, 2020, Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF, J Hepatol, 72, 688, 10.1016/j.jhep.2019.11.009 Zaccherini, 2021, Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF, J Hepatol, 74, 1117, 10.1016/j.jhep.2020.11.035 Zhang, 2022, Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure, J Hepatol, 76, 93, 10.1016/j.jhep.2021.08.009 Luan, 2019, GDF15 is an inflammation-induced central mediator of tissue tolerance, Cell, 178, 1231, 10.1016/j.cell.2019.07.033 Clària, 2021, Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis, J Hepatol, 75, 1116, 10.1016/j.jhep.2021.06.043 Weiss, 2023, Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET), Gut, 72, 1581, 10.1136/gutjnl-2022-328708 Gadano, 1999, Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis, Gut, 45, 117, 10.1136/gut.45.1.117 Mantovani, 2023, Humoral innate immunity and acute-phase proteins, N Engl J Med, 388, 439, 10.1056/NEJMra2206346 Ruiz-del-Arbol, 2005, Circulatory function and hepatorenal syndrome in cirrhosis, Hepatology, 42, 439, 10.1002/hep.20766